Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
HS, maybe shore could also google how oxygen is actually transported in the body for you. oxygen is carried by hemoglobin in the blood. electrolytes play a roll in the proper functioning of muscle and help to maintain the necessary ratio of water in cells to water outside of them. Also, you may be wrong about the drops not being able to eliminate the need for said powders. If the drops do what it has been speculated they will do (deliver a concentrated dose of electrolytes) pest can go back to just using water in his camelbak. judge not lest ye be judged (http://en.wikipedia.org/wiki/Blood#Oxygen_transport).
true. i was speaking more to main stream media. given the high profile individiuals with ALS, it would be a pretty clean story.
thank you for continuing to post the news. i cannot believe this has not been picked up in the US yet.
i agree and share your concern. it is going to take some heavy lifting by the athletes to get the word out there and earn whatever compensation it is they actually get. the nice thing about fuse is, at least from a scientific and marketability standpoint, there is substance. It makes the less than aggressive marketing/pumping bearable.
Better to do it right. As I said in an early post, the drops are essentially unknown to most of the world. Only the small number of investors even know they will be coming out. The larger public is not so anxious, and it is more important for Fuse to have a clean launch in the eyes of the public than to be "on time" in the eyes of the small number of impatient investors. Again, the company is not pandering to those who were looking to get rich quick and trade this like a penny stock. They are setting up for the long haul.
Monster was Hansen's soda and was a legitimate company for 30 years. Monster was just more profitable and marketable. So, the company was not a startup that exploded. It was an established company that struck gold. Only the second part applies to Fuse as Fuse has marketable and promising products, and that is why Monster is somewhat useful as a comparison.
thank you for the response. well said.
impact of larger market forces? anyone who believes this stock is impacted by the larger market forces care to explain the low correlation? if a stock does not follow the market up, or down, I am inclined to believe it does not follow the market.
Pretty sure its just Paul Rodriguez until he is wearing something with Fuse in large, bright letters.
good news, Joe Q consumer does not read PRs. To the larger public, it will not matter when the drops come out. All that matters is that they are launched well, delivered quickly, and provide something the people want. As for the Joe Q investors, they follow the masses.
yea. from what i have read about method patents they take years and less than half are approved.
any idea how long it takes to get a method patent approved?
I think the best answer is we do not know. We can infer from recent statements by Fuse that they are looking to create some sort of extended release caffeine delivery system, but beyond that we do not know.
yea. i would not be surprised to see some new shares out there, but still nothing to be surprised, shocked, or worried about.
it must be your birthday. congrats on those.
exactly. not to keep bringing up monster, but following their marketing targets is not exactly a bad idea (they are a major X games sponsor).
didnt want to exaggerate. paul rodriguez has a huge following, and this exposes Fuse to the "alternative" sports market. I would take this representative and drop every NFL player (other than Foster).
if RGIN gets a DOD contract (and the DoD is absolutely pumping money into regenerative medicine) the share price will not matter at all. At these prices we are in low enough that should the company find itself on sound financial footing (which a DoD grant would provide), the worst outcome would be a buy out from a bigger company.
they actually break it down in the PR exactly what they got of the study. i suggest you read my post about it from yesterday, and then actually read the PR. They put it in business terms, which I assume you can understand.
which said...
good marketing. a few thousand teenagers buying drops will not hurt sales figures.
FDA orphan drug approval is given to products that are targeted at diseases that affect a very small proportion of the population, and thus will have relatively small financial return. The designation gives the company 7 years of exclusive sales which is about twice what most drugs end up with following final FDA approval. It does not mean the product can be used for anything other than research/trials as of now. That requires further approval from the FDA.
That is indeed a great one sentence summary of what Fuse claims they have. The sample size was too small, and it really didn't give enough details, but the study released today shows that Fuse does have something going for it. The methods are not new, the speed and control seem to be. What it does do is support the idea that Fuse is ready, willing, and able to mass market the transdermal delivery system which has never been directed at the larger public before. Also, if you read the PR they put out, a delayed release caffeine roll on has the potential to absolutely dominate the "energy supplement" (redbull, monster, 5 hour energy) market. That is just one application they are talking about. Very interesting things to come from Fuse. Also interesting, they clearly state that they are developing a roll on application instead of the iontophoretic delivery vehicle mentioned in previous releases.
which technology has competition? Yesterday people discussed a completely different product with the same name. A gel, not a drop, nor a muscle rub. Who has drops coming out? who has them out?
just seems like a simple distinction. the rub or the gel pack. probably towards the bottom on the list of things to worry about, although it is nice that the list is short enough for people to get there.
but its a different product. i really cannot imagine someone looking for a muscle/joint rub, and getting directed towards energy supplements. again, different products. different parts of the store. different categories online.
could you elaborate please?
why is that an issue? they won't be next to each other in stores. the only issue would be searching for it online, and even then they would be under different categories.
http://www.gnc.com/product/index.jsp?productId=2176125
they are completely different products with completely different packaging and purposes. the spelling is the only issue.
agreed. slow day for the market. nobody has much worth talking about.
a very interesting thought.
i like the sentiment. however, pharma companies make money through exclusivity (and then marketing, just like every other consumer product).
true. anyone can make the stuff. college kids make aspirin in organic chemistry lab in college. however, i think if a company is going to throw some weight behind it, they will want to lock it up. it all depends on what Fuse has to offer though, and I do not think a firm answer to that question is available to the public yet.
many great questions and posts so far today. the pharma side of things is very interesting to me, on both the personal and investor side of things. however, the drops, if executed properly, can quickly and easily find themselves in the middle of the supplement market which is huge, growing, and easily accessible (insert some sort of dirty joke here).
i doubt any pharma company would sign anything that did not give them exclusive rights for some period of time.
great post. many of Fuse's statements are vague, but they have done all the things they said they would. That is about all you can ask for a company at this stage.
per an earlier email i recieved from IR, the platforms started around december 20th of last year. trials will be required, but relatively painless given that any parts of a Fuse driven analgesic will used pieces that have already been approved. Fuse does not make anything. Cure produces the stuff. As fun as it is to speculate about possible pharma uses, the drops will be the muscle of this company.
welcome to the club.
I agree. The real, near term potential for this company is enerjel and the drop supplements.
simmer down. its just a possible use.
yup. same page. a lot of good PRs recently. a lot of exciting moves being made.